• Extension of Sunshine Reporting to NPs and PAs

• Recent Enforcement Initiatives and Proposed Changes in Regulations

• Trends in State-By-State Reporting

• Updates on Medical Device Reporting

• Data Privacy Deep Dive

• The Story behind Your Organization’s Data for Efficient Utilization

• Emerging Global Transparency Guidelines and Cross-Border Management

• Regulatory Frameworks to Successfully Manage HCP Interactions

• Updates on Price Transparency Reporting

• Third-Party Data Validation and Monitoring

• Compliance Risk Measures of Speaker Programs

• Metrics and Data Analytics to Ensure Compliance

ALL NEW PROGRAMMING FOR 2020!Benefit from devoted, customizable tracks on:

Industry’s Largest, Longest-Running and Most Anticipated Event Delivers Best Practices to Streamline the Submission Process and Leverage Data Analytics to Drive Compliant Operations

W W W.CBINET.COM/AGGSPEND

TTransparency & Aggregate Spend

14th Annual Forum on

AUGUST 12-14, 2020 | THE RITZ-CARLTON | WASHINGTON, DC

Definitive Solutions and Trends for High-Risk Areas in State, Open Payments and Global Reporting Requirements

Brought to you by

an informa business

HCP Risk Management

Data Analytics

Global Transparency

COMPLIANCE & LEGAL SERIES

Day One — Tuesday, August 11, 2020 7:30 Workshop Registration

8:30

CHOOSE BETWEEN 1 OF THE 3 CONCURRENT WORKSHOPS (A-C)

Device, Dental and Distributor Transparency ReportingA Speaker Program Monitoring B Third-Party Risk

Management and Oversight C10:30 Networking and Refreshment Break

12:00 Close of Pre-Conference Workshops, Networking Luncheon Commences

12:30 Afternoon Summit Registration

1:30

CHOOSE BETWEEN 1 OF THE 2 CONCURRENT AFTERNOON SUMMITS (I-II)

Guidebook for Beginner’s on Open Payments Reporting I Closed-Door Open Payments Summit —

Prelude for ExpertsII3:00 Networking and Refreshment Break

5:00 Networking Wine and Cheese Reception

Day Two — Wednesday, August 12, 2020 7:15 Main Conference Registration and Continental Breakfast

8:15 Conference Chair’s Welcome and Opening Remarks

8:30 CMS Town Hall — Keynote Address and Panel Discussion

9:30 PANEL DISCUSSION • Execution of the Sunshine Act Expansion

10:15 Networking and Refreshment Break

10:45 ENFORCEMENT AND INDUSTRY PANEL DISCUSSION • The Latest on Government Expectations vs. Reality and High-Risk Areas to Closely Monitor

11:45 PANEL DISCUSSION • Spotlight on Price Transparency Reporting — Impactful Trends to Know

12:30 Networking Luncheon

1:45 WORKSTREAMS COMMENCE — CHOOSE TO ATTEND 1 OF THE 3 CONCURRENT WORKSTREAMS (I- I I I)

1:45 Reduce Risk and Maximize Compliance Across the HCP/HCO Engagement Process

2:30 Examine the Impact of FCPA on HCP Interactions

3:15 Networking and Refreshment Break

3:45 Overcome Challenges in Contract Management to Streamline HCP Operations

4:30 Assess the HCP FMV Framework

1:45 PANEL DISCUSSION • Essential Overview of the Country-by-Country Landscape

2:30 Assess Various Technologies to Support Global Transparency Reporting

3:15 Networking and Refreshment Break

3:45 Best Practices for Navigating Consent and Cross-Border Management

4:30 Examine the Updates on Medical Device — Global Transparency Reporting

1:45 Ensure Quality of Data Collection and Systems

2:30 Explore the Use of A.I. in Compliance Programs

3:15 Networking and Refreshment Break

3:45 Streamline Customer Master Data Management

4:30 Examine the Utilization of Transparency Data to Mitigate Risk

I. Risk Management in HCP Interactions II. Global Transparency Reporting III. Data Collection, Analytics and A.I.

5:15 Close of Day Two / Wine and Cheese Networking Reception

AGENDA AT-A-GLANCE

Day Three — Thursday, August 13, 2020 7:30 Continental Breakfast

8:00 Conference Chair’s Review of Day Two

8:15 ABPI Address — UK’s Disclosure Experience and Updates to the ABPI Code

9:15 Gain Critical Insights into the Current Data Privacy Landscape

10:00 Networking and Refreshment Break

10:30 WORKSTREAMS COMMENCE — CHOOSE TO ATTEND 1 OF THE 3 CONCURRENT WORKSTREAMS (I- I I I)

10:30 Key Strategies for Managing Global HCP Activities

11:15 Effective Strategies to Streamline HCP Dispute Management

10:30 101 — How to Get Started on Implementing Global Data Analytics

11:15 Benchmark with Industry Peers on Global Patient Organization Reporting

10:30 CMS Review — Keys to Preparing and Reporting for CMS Audits

11:15 Post CIA — Lessons Learned to Remain Compliant

I. Risk Management in HCP Interactions II. Global Transparency Reporting III. Data Collection, Analytics and A.I.

12:00 Networking Luncheon

1:45 Practical Strategies for Properly Capturing and Reporting T&E Spend

2:45 Leverage Transparency Data for Informed Business Decisions

3:30 Close of Conference

Great conference! The content that was presented was very

beneficial and relevant!– Manager, Aggregate Spend,

Alcon Laboratories, Inc.

Tweet your learnings #AggSpend2020

Join our LinkedIn Community CBI Compliance Series

STAY CONNECTED AND JOIN THE CONVERSATION

WEBSITE:cbinet.com/aggspend

EMAIL juliet.nelson@informa.com

PHONE800.817.8601

3 EASY WAYS TO REGISTER

1 2 3

See You in See You in Washington, DCWashington, DC

2019 HIGHLIGHTS

2019 FORUM FACTS

Live Benchmarking

2 In-Depth Workshops

4 Working Groups

CMS Keynote

8 Customizable

Breakouts

OUR LIFE SCIENCES AUDIENCE PROFILE

A Look Into Why Transparency and Aggregate Spend Has Been the Gold Standard Event for the Last Decade

3450+ Attendees

575+ Expert Speakers

675+ Companies Have Benefited

49% Compliance / Legal

32% Transparency / Reporting / Agg Spend

10% Finance / Accounting

4% Data / Systems

3% Commercial Operations / Affairs

2% Clinical / Regulatory Affairs

62% Small

19% Upper-Mid

10% Mid

9% Large

Prelude for Experts

FORUM FEEDBACK100% of surveyed attendees…

Left satisfied

Had their objectives met

Found the event valuable for their time

Found the event valuable for their money

Are likely to recommend the event to a colleague

INDUSTRY EXPERTS DRIVE THE DIALOGUE EACH YEAR

Corey Amundson, Director and Chief Counsel, Office of Professional Responsibility, U.S. Department of Justice

Melissa Blaco, Director, Compliance Reporting, Regeneron Pharmaceuticals

Brian Bohnenkamp, Partner, King & Spalding LLP

Diana Borges, Vice President of Compliance Solutions, MediSpend

Tim Canonico, Partner, PwC

Cheryl Chamallas, Director, Ethics and Compliance, Alnylam Pharmaceuticals

Nicole Colapietro, Manager, Transparency Reporting Group, Olympus Corporation of the Americas

Sean Collins, HCP Transparency Analyst, Smith & Nephew

Melissa Cox, Data Compliance Officer, Spectrum Pharmaceuticals

Emily Cunningham, Associate Principal, IQVIA Commercial Compliance

Nicodemo Fiorentino, Senior Manager, Compliance Operations & Transparency, SUN PHARMA

Robert Forcier, HCP Aggregate Spend Director, Smith & Nephew

Baris Goc, Director, Risk and Regulatory, PwC

Kimi Gorman, Senior Director Ethics & Compliance, Novo Nordisk

Michael Grandison, Senior Manager, Transparency, Regeneron Pharmaceuticals

Erik Gross, Consultant, NUI

Susan Hibbard, Associate Director, Office of Ethics and Compliance-Transparency and Compliance, Boehringer Ingelheim

Rachael Honig, First Assistant U.S. Attorney, U.S. Attorney’s Office District of New Jersey

Denise Jones, U.S. Ethics & Compliance Transparency Partner, UCB, Inc.

Louie Karapanagiotides, Manager, Helio Health Group

Shruti Anand Karkun, Senior Associate, Global Transparency Reporting, Covance, Inc.

Kari Loeser, US Healthcare Compliance Officer, Relypsa

Joseph Mack, Senior Compliance Counsel, U.S. Office of Compliance, Bayer U.S.

Sharon Muscato, Director, Transparency & Compliance Operations, Alexion Pharmaceuticals, Inc

Mallory O’Connor, Director Of Public Policy, Mallinckrodt Pharmaceuticals

Michael O’Connor, Vice President of Compliance Technology, Porzio Life Sciences, LLP

John Oroho, Executive Vice President & Chief Strategy Officer, Porzio Life Sciences, LLC

Mohammad Ovais, CEO, qordata

Michael Pace Senior Director, Enterprise Sales – Life Sciences Market, U.S., SAP Concur

Jennifer Parsons, Director, US Transparency & Compliance Operations, Biogen

April Pierce, Associate Director, Global Spend Transparency, Sage Therapeutics

Andrea Pucci, Senior Legal & Compliance Advisor, Medicines for Europe

Margaret Rossini, Director, Corporate Compliance Monitoring and Risk, Sandoz Inc.

Carol M. Seaman, Vice President, Global Chief Ethics & Compliance Officer, Cook Group

Brian Sharkey, Vice President, Porzio Life Sciences, LLP

Emily Singh, Director, PwC

Rhonda Sobral O’Toole, Esq., Director, Compliance Reporting and Systems, Ferring Pharmaceuticals Inc.

Bryan Stefanski, Compliance Director, Siemens Medical Solutions USA, Inc.

Tom Sullivan, President, Policy & Medicine

Wendy Sward, Senior Solution Consultant, Life Sciences, SAP Concur

Kelly Tope, Esq., MBA, Global Director, Compliance, Zimmer Biomet

Jeffrey Trull, Global Transparency/Financial Systems Manager, Covance, Inc.

Robin Usi, Director, Division of Data and Informatics, Center for Program Integrity, Data Sharing and Partnership Group, Centers for Medicare and Medicaid Services (CMS)

David Vulcano, Vice President, Research, Compliance, & Integrity, HCA Healthcare

Kiran Vuppala, Assistant Vice President, Compliance Technology, Porzio Life Sciences, LLC

Matt Wetzel, Senior Counsel, Akin Gump Strauss Hauer & Feld LLP, Former Vice President & Deputy General Counsel, AdvaMed

Donna White, Vice President, Contracts & Compliance, Chiesi

CONTINUING EDUCATION

• Industry-specific expertise and CLE, CPE and CCB* accredited content *pending approval

• Dynamic and highly-acclaimed perspectives

• Customizable programming with 3 Pre-Conference Workshops, 2 Summits and 3 Content Workstreams

PROFESSIONAL DEVELOPMENT

• Engage with 250+ like-minded professionals• Multiple peer-to-peer receptions and networking opportunities • Career path conversations and talent development opportunities

BUSINESS INNOVATION

• Real-time industry benchmarking to align best practices• Interactive conference app to enhance the on-site experience

THE MANY REASONS TO JOIN US IN 2020

CONGRESS SPONSORS

Device, Dental and Distributor Transparency Reporting Speaker Program Monitoring Third-Party Risk Management

and Oversight

Guidebook for Beginner’s on Open Payments Reporting

Closed-Door Open Payments Summit — Prelude for Experts

Risk Management in HCP Interactions Global Transparency Reporting Data Collection, Analytics and A.I.

3 PRE-CONFERENCE WORKSHOPS

2 PRE-CONFERENCE SUMMITS

3 TAILORED WORKSTREAMS

Tweet your learnings #AggSpend2020

Join our LinkedIn Community CBI Compliance Series

Another successful conference — excellent opportunity to catch-up with industry friends and hear from my peers! – Manager, Aggregate Spend,

Alcon Laboratories, Inc.

Great conference and venue. Tons of relevant topics and plenty of same-field colleagues looking to remain in compliance with current and future federal/state regulations.– Associate Director, Transparency, UCB

I’m a firm believer that these conferences are the backbone of learning and leveraging knowledge for all peers in the transparency landscape regardless of being Medical Device or Pharma.– Lead Compliance Audit Analyst, Philips Healthcare

In addition to the networking opportunities the conference has a lot to offer from the open forum layout encouraging an exchange of trends, obstacles and wins shared by some well-educated and experienced attendees. – Aggregate Spend Analyst, Chiesi

This was beneficial for our company because we learned best practice on some of our consuming processes. We were able to get some answers to our questions concerning CMS and learned about the new lobbing rules that may affect medical tech.– Sr Global Transparency Specialist, Wright Medical

WHAT PREVIOUS ATTENDEES HAD TO SAY

STAY CONNECTED AND JOIN THE CONVERSATION

COMPLIANCE & LEGAL SERIES www.cbinet.com/aggspend

REACH OUT TO THE #AGGSPEND2020 TEAM

Brought to you by

an informa business

PROGRAM DEVELOPMENT:

Erica Vallecorsa erica.vallecorsa@informa.com 339-298-2153

SPONSORSHIP OPPORTUNITIES:

John Egan john.egan@informa.com 339-298-2205

REGISTRATION & TEAMS:

Juliet Nelson juliet.nelson@informa.com 339-298-2140